ATF3 mRNA, but not BTG2, as a possible marker for vital reaction of skin contusion.
Sign Up to like & getrecommendations! Published in 2019 at "Forensic science international"
DOI: 10.1016/j.forsciint.2019.109937
Abstract: The detection of vitality of wounds, especially when the wounds are inflicted very close to the time of death, is one of the most challenging issues in forensic pathology. This study investigated expression levels of… read more here.
Keywords: btg2; atf3 btg2; skin; atf3 mrna ... See more keywords
LncRNA MIR600HG inhibits laryngeal cancer development by mediating the miR‐424‐5p/BTG2 axis
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Science"
DOI: 10.1111/cas.16404
Abstract: Laryngeal carcinoma is the predominant kind of tumor seen under the category of head and neck malignancies. LncRNA MIR600HG affects tumor morphology in numerous cancer types. However, the function of MIR600HG in laryngeal cancer remains… read more here.
Keywords: mir 424; cancer; laryngeal cancer; lncrna mir600hg ... See more keywords
LncRNA CARMN inhibits cervical cancer cell growth via the miR-92a-3p/BTG2/Wnt/β-catenin axis.
Sign Up to like & getrecommendations! Published in 2022 at "Physiological genomics"
DOI: 10.1152/physiolgenomics.00088.2022
Abstract: Long non-coding RNA cardiac mesoderm enhancer-associated non-coding RNA (CARMN) is a newly discovered tumor-suppressor lncRNA in cancers. However, its role in cervical cancer (CC) remains elusive. This study was conducted to analyze the molecular mechanism… read more here.
Keywords: carmn; btg2; cell growth; mir 92a ... See more keywords
B-Cell Translocation Gene 2 Upregulation Is Associated with Favorable Prognosis in Lung Adenocarcinoma and Prolonged Patient Survival
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/1892459
Abstract: The tumor suppressor protein B-cell translocation gene 2 (BTG2) is downexpressed in lung adenocarcinoma (LUAD); however, its role in LUAD survival remains unknown. This investigation is aimed at exploring the activity of BTG2 in LUAD.… read more here.
Keywords: btg2; cell; cell translocation; lung adenocarcinoma ... See more keywords
BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1049928
Abstract: The biological functions of N6-methyladenosine (m6A) modification of mRNA have recently received a great deal of attention. In previous studies, m6A methylation modification has been shown to regulate mRNA fate and to be crucial for… read more here.
Keywords: cell carcinoma; cell; modification; renal cell ... See more keywords
DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling
Sign Up to like & getrecommendations! Published in 2022 at "Acta Biochimica et Biophysica Sinica"
DOI: 10.3724/abbs.2022194
Abstract: The outcome of pancreatic adenocarcinoma (PAAD) patients is poor, given resistance to gemcitabine. Long noncoding RNA (lncRNA) has been implicated in the carcinogenesis of pancreatic cancer; however, its function and mechanism in PAAD resistance to… read more here.
Keywords: dscr9; proliferation; pancreatic cancer; btg2 ... See more keywords
MLN4924 promotes transcriptional activation of BTG2 via ROS/EGR1-mediated signaling axis to suppress acute myeloid leukemia progression
Sign Up to like & getrecommendations! Published in 2025 at "Acta Biochimica et Biophysica Sinica"
DOI: 10.3724/abbs.2025194
Abstract: Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy characterized by a high relapse rate and a low survival rate. Although chemotherapy and allogeneic hematopoietic stem cell transplantation (allo-HSCT) have improved the prognosis for… read more here.
Keywords: ros; acute myeloid; aml; btg2 ... See more keywords